Margonis GA, et al. – This study focused on preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases. Findings revealed enhanced volumetric restoration with preoperative bevacizumab administration along with chemotherapy. Interestingly, this effect was more pronounced among patients who received oxaliplatin–based regimens and bevacizumab compared to those treated with irinotecan–based regimens and bevacizumab.